Stem Cell-Based or Cell-Free Gene Therapy in Chondrocyte Regeneration: Synovial Fluid-Derived Mesenchymal Stem Cell Exosomes.
Onur UysalHaya ErybehMediha CanbekEmilia Qomi EkenelSibel Gunes BagisGülay BüyükköroğluTugba Semerci SevimliFatih CemrekAyla Eker SariboyaciPublished in: Current molecular medicine (2023)
It was concluded that hSF-MSCs and exosomes can be used in the treatment of cartilage damage, and hsa-miR-155-5p can be used as a target miRNA in a new gene therapy approach because it increases the therapeutic effect on cartilage damage.